Yonsei Med J.  2015 Jul;56(4):1079-1086. 10.3349/ymj.2015.56.4.1079.

The Prognostic Value of Individual Adhesion Scores from the Revised American Fertility Society Classification System for Recurrent Endometriosis

Affiliations
  • 1Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. dr222@yuhs.ac
  • 2Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.
  • 3Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Obstetrics and Gynecology, Gil Hospital, Graduate School of Medicine, Gachon University of Medicine and Science, Incheon, Korea. dongwook@gilhospital.com

Abstract

PURPOSE
This study aimed to evaluate the prognostic value of each component of the revised American Fertility Society (rAFS) classification system for the first recurrence of endometriosis after conservative laparoscopy.
MATERIALS AND METHODS
As this was a retrospective cohort study, data were collected by reviewing medical records. A total of 379 women ages 18 to 49 years were included. Women who underwent conservative laparoscopy with histologic confirmation of endometriosis at Gangnam Severance Hospital between March 2003 and May 2010 were included. Individual components of the rAFS classification system as well as preoperative serum CA-125 levels were retrospectively analyzed to assess their prognostic values for recurrence of endometriosis.
RESULTS
Of 379 patients, 80 (21.2%) were found to have recurrence of endometriosis. The median duration of follow-up was 19.0 months, and the mean age at the time of surgery was 31.8+/-6.7 years. In endometriosis of advanced stage, younger age at the time of surgery, bilateral ovarian cysts at the time of diagnosis, a rAFS ovarian adhesion score >24, and complete cul-de-sac obliteration were independent risk factors of poor outcomes, and a rAFS ovarian adhesion score >24 had the highest risk of recurrence [hazard ratio=2.948 (95% CI: 1.116-7.789), p=0.029].
CONCLUSION
Our results suggest that of the rAFS adnexal adhesion scores, the ovarian adhesion score rather than the tubal adhesion score was associated with a significantly increased risk of recurrent endometriosis. The preoperative serum CA-125 level may be also a significant prognostic factor for recurrence, as known. However, it seemed to only have borderline significance in affecting recurrence in the current study.

Keyword

Endometriosis; recurrence; prognostic factor; rAFS classification; ovarian adhesion

MeSH Terms

Adolescent
Adult
Cohort Studies
Endometriosis/*classification/*surgery
Female
Fertility
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Laparoscopy/*methods
Middle Aged
Prognosis
Recurrence
Retrospective Studies
Risk Factors
*Tissue Adhesions
Treatment Outcome
United States

Figure

  • Fig. 1 Cumulative incidence of recurrent endometriosis for different ovarian adhesion score groups. (A) Patients divided into four groups. (B) Groups with a cut off level of 24.


Cited by  1 articles

Preoperative risk factors in recurrent endometrioma after primary conservative surgery
Seung Joo Chon, Seung Hyeong Lee, Joo Hyun Choi, Ji Sung Lee
Obstet Gynecol Sci. 2016;59(4):286-294.    doi: 10.5468/ogs.2016.59.4.286.


Reference

1. Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010; 362:2389–2398.
2. Farquhar CM. Extracts from the "clinical evidence". Endometriosis. BMJ. 2000; 320:1449–1452.
3. Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. PA, USA: Lippincott Williams & Wilkins;2011.
4. Cheong Y, Tay P, Luk F, Gan HC, Li TC, Cooke I. Laparoscopic surgery for endometriosis: how often do we need to re-operate? J Obstet Gynaecol. 2008; 28:82–85.
Article
5. Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007; 109:1411–1420.
Article
6. Fedele L, Bianchi S, Zanconato G, Bettoni G, Gotsch F. Long-term follow-up after conservative surgery for rectovaginal endometriosis. Am J Obstet Gynecol. 2004; 190:1020–1024.
Article
7. Kikuchi I, Takeuchi H, Kitade M, Shimanuki H, Kumakiri J, Kinoshita K. Recurrence rate of endometriomas following a laparoscopic cystectomy. Acta Obstet Gynecol Scand. 2006; 85:1120–1124.
Article
8. Vercellini P, Fedele L, Aimi G, De Giorgi O, Consonni D, Crosignani PG. Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Hum Reprod. 2006; 21:2679–2685.
Article
9. Vignali M, Bianchi S, Candiani M, Spadaccini G, Oggioni G, Busacca M. Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol. 2005; 12:508–513.
Article
10. Revised American. 1996. Fertil Steril. 1997; 67:817–821.
11. Koga K, Osuga Y, Takemura Y, Takamura M, Taketani Y. Recurrence of endometrioma after laparoscopic excision and its prevention by medical management. Front Biosci (Elite Ed). 2013; 5:676–683.
Article
12. Hart RJ, Hickey M, Maouris P, Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008; CD004992.
Article
13. Fujishita A, Khan KN, Masuzaki H, Ishimaru T. Influence of pelvic endometriosis and ovarian endometrioma on fertility. Gynecol Obstet Invest. 2002; 53:Suppl 1. 40–45.
Article
14. Cho S, Cho H, Nam A, Kim HY, Choi YS, Park KH, et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril. 2008; 90:2073–2079.
Article
15. Medl M, Ogris E, Peters-Engl C, Mierau M, Buxbaum P, Leodolter S. Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis. Br J Obstet Gynaecol. 1997; 104:78–81.
Article
16. Lee DY, Kim HJ, Yoon BK, Choi D. Factors associated with the laterality of recurrent endometriomas after conservative surgery. Gynecol Endocrinol. 2013; 29:978–981.
Article
17. Lee DY, Bae DS, Yoon BK, Choi D. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod. 2010; 25:3050–3054.
Article
18. Spaczynski RZ, Duleba AJ. Diagnosis of endometriosis. Semin Reprod Med. 2003; 21:193–208.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr